North University Pharma's 1.4 billion merger and acquisition of integrated medical oncology diagnosis and treatment equipment patent dispute

Daily Economic Journalist Song Gothe suspension of thePeking UniversityPharmaceutical(000788, the previous closing price of 13.41 yuan) announced the acquisition plan, the company intends to issue shares through the issuance of shares to acquire the Shenzhen-in-oneMedicalTechnology Co., Ltd(hereinafter referred to as-in-oneMedical) 100% of the sharesThe company's shares will resume trading on June 18"Daily Economic News" reporter noted that one medical company's shares of a number of medical-related companiesthe northpharmaceuticalof the equipment products, and one of the ultrasound cirrhosis detector by another listed company, Fury shares (300049, closing price of 28.41 yuan) denounced as imitation, Fury shares said it will take necessary action to safeguard their rights and interests to build a cancer treatment industry chain / announcement shows that Peking University Pharmaceuticals intends to issue 106 million shares to one group, one-in-one Zhengrun and Jin Yixin and a total of 106 million shares at the price of 13.29 yuan/share, to buy 100% of its holding of one-in-one medical shares; According to data, the estimated value of 100% equity in One Medical is about RMB1,402 million, an increase of 330.10% over the net asset valuation of RMB326 million as of the end of April 2014 For the reason sione premium is so high, the company mentioned mainly because of integrated medical as a high-tech company, the main business continues to grow, the benefits of stable rise, the future development prospects are more ideal; data show that integrated medical to "medical equipment research and development manufacturing sales" and "medical equipment overall solution" two modules as the core business, is committed to become a professional tumor diagnosis and treatment of equipment overall solution provider On the one hand, the company directly produces and sells gamma knife with independent intellectual property rights, ultrasonic cirrhosis detector, whole body heat treatment system, whole body red light treatment system and other products, on the other hand, through the project cooperation to provide medical institutions, including independent research and development products, outsourcing PET-CT, linear accelerator, including a variety of tumor diagnosis and treatment equipment, and provide corresponding supporting value-added services financial data show that in 2012, 2013 and January-April 2014, integrated medical revenues of 227 million yuan, 243 million yuan and 109 million yuan, respectively, net profit of 0.41 billion yuan, 0.57 billion yuan and 0.25 billion yuan , Peking University Pharmaceuticals said it will acquire integrated medical treatment to create a whole industrial chain of anti-tumor drug treatment, while officially entering the field of medical services OfFrey shares: one medical imitation products / For such a more than 1 billion yuan asset acquisition, the transaction side also gave a performance commitment, if the transaction is completed in 2014, then integrated medical 2014-2016 net profit is not less than 74.6365 million yuan, 933.293 million yuan and 124 million yuan, if the transaction is completed in 2015, the net profit of Integrated Medical 2015-2017 will not be less than 933.293 million yuan, 124 million yuan and 149 million yuan On this basis, the average annual growth rate of integrated medical net profit in the future will reach 30% However, "Daily Economic News" reporter found that one medical one of the ultrasound cirrhosis detector has been "targeted" by Fury shares data show that The main product of Fury's shares, the hepatic fibrosis ultrasound diagnostic instrument FibroScan, is developed and sold by the wholly-owned subsidiary Echoen of France Last year, the series achieved operating income of 180 million yuan, accounting for 523 million yuan of the company's revenue of 34.4%, and become the company's main source of profits is worth noting that Integrated Medical also has an ultrasound cirrhosis detector, and called it Asia's first noninvasive diagnostic hepatitis fibrosis and cirrhosis detector with fully independent intellectual property rights, using the latest ultrasound elastic imaging technology both products are noninvasive diagnostic liver fibrosis and cirrhosis detector, to which Fury shares in the Great Wall Securities research report responded that FibroScan has appeared imitation, one medical is one of them, the company will take necessary action to safeguard their legitimate rights and interests click to enter the Stock Club to participate in the discussion